These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22997913)

  • 1. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
    Rudenko TE; Kutyrina IM; Shvetsov MIu
    Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors for cardiovascular system damage in chronic kidney disease].
    Kutyrina IM; Rudenko TE; Savel'eva SA; Shvetsov MIu; Vasil'eva MP
    Ter Arkh; 2013; 85(9):69-76. PubMed ID: 24261233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
    Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure].
    Kutyrina IM; Rudenko TE; Shvetsov MIu; Kushnir VV
    Ter Arkh; 2008; 80(6):37-41. PubMed ID: 18655474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
    Tomilina NA; Gendlin GE; Zhidkova DA; Tronina OA; Fedorova ND
    Ter Arkh; 2009; 81(8):42-8. PubMed ID: 19799199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease.
    Rudenko TE; Kamyshova ES; Vasilyeva MP; Bobkova IN; Solomakhina NI; Shvetsov MY
    Ter Arkh; 2018 Sep; 90(9):60-67. PubMed ID: 30701737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
    Datta S; Abraham G; Mathew M; Somasundaram H; Muralidharan TR; Moorthy A; Sathyasekaran ; Leslie N
    J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variants of heart remodeling in essential hypertension: prevalence and determinants].
    Konradi AO; Rudomanov OG; Zakharov DV; Vakhrameeva NV; Krutikov AN; Iakovleva OI; Shliakhto EV
    Ter Arkh; 2005; 77(9):8-16. PubMed ID: 16281481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3.
    Pluta A; Stróżecki P; Krintus M; Odrowąż-Sypniewska G; Manitius J
    Ren Fail; 2015 Aug; 37(7):1105-10. PubMed ID: 26156686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
    Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
    Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.
    Sambi RS; Gaur AK; Hotchandani R; Aggarwal KK; Kaur S; Gupta M; Jain S; Krishna CK; Chopra HK; Anand V; Srivastava S; Gupta R; Parashar SK
    Indian Heart J; 2011; 63(3):259-68. PubMed ID: 22734347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of combined target-organ damage in patients with essential hypertension.
    Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
    Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular geometry in children with mild to moderate chronic renal insufficiency.
    Matteucci MC; Wühl E; Picca S; Mastrostefano A; Rinelli G; Romano C; Rizzoni G; Mehls O; de Simone G; Schaefer F;
    J Am Soc Nephrol; 2006 Jan; 17(1):218-26. PubMed ID: 16280471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
    Cea-Calvo L; Conthe P; Gómez-Fernández P; de Alvaro F; Fernández-Pérez C;
    Cardiovasc Diabetol; 2006 Nov; 5():23. PubMed ID: 17083718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.